Winebrenner Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Sell
439
-153
-26% -$156K 0.32% 87
2026
Q1
$545K Sell
592
-17
-3% -$17.2K 0.35% 81
2025
Q4
$654K Hold
609
0.44% 68
2025
Q3
$465K Hold
609
0.33% 86
2025
Q2
$475K Buy
609
+144
+31% +$112K 0.38% 80
2025
Q1
$384K Sell
465
-154
-25% -$128K 0.35% 85
2024
Q4
$478K Buy
+619
New +$513K 0.37% 84

Other funds holding LLY

Winebrenner Capital Management's LLY Position: Q2 2026 in Review

Winebrenner Capital Management reduced its Eli Lilly (LLY) stake by 26% in Q2 2026, selling an estimated $156K and leaving 439 shares worth $527K. The position accounts for 0.32% of the portfolio, ranked #87.

Winebrenner Capital Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $654K in Q4 2025. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Winebrenner Capital Management held 439 shares of Eli Lilly worth $527K as of Q2 2026.
  • Winebrenner Capital Management sold 153 Eli Lilly shares in Q2 2026, an estimated $156K.
  • Eli Lilly made up 0.32% of Winebrenner Capital Management's portfolio in Q2 2026, its #87 holding.
  • Winebrenner Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Winebrenner Capital Management's Eli Lilly position peaked at $654K in Q4 2025.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Winebrenner Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.